Table 2 Clinicopathological features of pancreatic cancer cases.
From: The diagnostic value of LncRNA NEAT1 targeting miR-129-5p in pancreatic cancer patients
Clinicopathologic features | PC patients n (%) | |
|---|---|---|
pT stage | T2 | 25 (41.7) |
T3 | 14 (23.3) | |
T4 | 21 (35) | |
pN stage | N1 | 14 (23.3) |
N2 | 46 (76.7) | |
TNM staging | Stage II | 14 (23.3) |
Stage III | 34 (56.7) | |
Stage IV | 12 (20) | |
TNM staging groups | Curative ( II & III) | 48 (80) |
Metastatic (IV) | 12 (20) | |
Tumor grading | G2 | 45 (75) |
G3 | 15 (25) | |
